Earnings Call Summary | Sophia Genetics(SOPH.US) Q1 2024 Earnings Conference
Earnings Call Summary | Sophia Genetics(SOPH.US) Q1 2024 Earnings Conference
The following is a summary of the SOPHiA GENETICS SA (SOPH) Q1 2024 Earnings Call Transcript:
以下是 SopHia GENETICS SA（SOPH）2024年第一季度财报电话会议记录的摘要：
Financial Performance:
财务业绩：
SOPHiA GENETICS reported Q1 revenue of $15.8 million, a 13% increase from the same quarter the previous year.
Adjusted gross margins were above 70% despite a decrease in clinical volume and biopharma demand.
Adjusted operating loss decreased by 13% year-over-year, reaching $14.1 million.
There was a 26% year-over-year growth in shipments of partner wet lab components.
The operating loss in Q1 2024 slightly decreased to $18.8 million from $19.3 million in Q1 2023.
Adjusted gross profit was $11.1 million, showing a 9.9% increase from Q1 2023.
Adjusted gross margin for Q1 2024 was 70.5%.
SopHia GENETICS公布的第一季度收入为1,580万美元，比去年同期增长13％。
尽管临床量和生物制药需求有所下降，但调整后的毛利率仍超过70％。
调整后的营业亏损同比下降13％，达到1410万美元。
合作伙伴湿式实验室组件的出货量同比增长了26％。
2024年第一季度的营业亏损从2023年第一季度的1,930万美元略有下降至1,880万美元。
调整后的毛利为1,110万美元，比2023年第一季度增长9.9％。
2024年第一季度调整后的毛利率为70.5％。
Business Progress:
业务进展：
Strong growth momentum noted in the U.S market with a 34% increase in analyses volume and a 27% increase in revenue in Q1.
SOPHiA GENETICS recently onboarded SOPHiA DDM in the oncology operations of the Mayo Clinic.
A comprehensive deal was signed with Strand Life Sciences in India.
The company added 27 new logos in Q1, an increase from the 18 new logos from the previous year.
SOPHiA GENETICS launched a team of specialized subject matter experts to aid new clients.
The initiation of a breast cancer project and a $50 million debt financing agreement with Perceptive Advisors were announced to accelerate growth.
The company launched the MSK-ACCESS application and has already onboarded nine customers.
美国市场出现强劲的增长势头，第一季度分析量增长了34％，收入增长了27％。
SopHia Genetics最近加入了SopHia DDM，参与梅奥诊所的肿瘤业务。
与印度斯特兰德生命科学公司签署了一项全面的协议。
该公司在第一季度增加了27个新徽标，比上年的18个新徽标有所增加。
SopHia GENETICS成立了一个由专业主题专家组成的团队，为新客户提供帮助。
宣布启动乳腺癌项目并与Perceptive Advisors签订5000万美元的债务融资协议，以加速增长。
该公司推出了MSK-ACCESS应用程序，已经吸引了九名客户。
More details: Sophia Genetics IR
更多详情： 索菲亚遗传学 I
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多详情，请访问投资者关系网站。本文仅供投资者参考，不构成任何投资建议。
译文内容由第三方软件翻译。